BridgeMD
New treatment option for Vocal Cord Disease
Official title Effect of Superior Laryngeal Nerve Blocks on Patient Outcomes in Laryngeal Surgery
ClinicalTrials.gov ID: NCT06734975
What this study is testing
What is Superior laryngeal nerve block - Intervention (Bupivacaine and triamcinolone acetonide suspension)?
Superior laryngeal nerve block - Intervention (Bupivacaine and triamcinolone acetonide suspension) is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for vocal cord disease.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Patients undergoing surgery on their vocal cord will either receive a numbing injection to their throat or a saline injection during surgery. Symptoms such as how much coughing or pain patients have after surgery, as well as whether patient's voice gets better will be interrogated.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient is aged 18 years or older at time of consent
- Patient has suspected or confirmed benign vocal fold lesion
- Patient is planning to undergo direct laryngoscopy with excision of the vocal fold lesion
- Patient is English or Spanish speaking
- Patient is not pregnant per self report
You likely can't join if
- Patient is not 18 years of age or older at consent date
- Patient does not speak English or Spanish
- Patient is currently pregnant or plans to become pregnant prior to their study procedure
- Patient has a laryngeal malignancy or found to find a laryngeal malignancy on final pathology
- Patient will not be undergoing direct laryngoscopy with excision of lesion
- Patient is unable to provide consent or complete study activities
See the full eligibility criteria
- Patient is aged 18 years or older at time of consent
- Patient has suspected or confirmed benign vocal fold lesion
- Patient is planning to undergo direct laryngoscopy with excision of the vocal fold lesion
- Patient is English or Spanish speaking
- Patient is not pregnant per self report
- Patient is not incarcerated
- Patient is not 18 years of age or older at consent date
- Patient does not speak English or Spanish
- Patient is currently pregnant or plans to become pregnant prior to their study procedure
- Patient has a laryngeal malignancy or found to find a laryngeal malignancy on final pathology
- Patient will not be undergoing direct laryngoscopy with excision of lesion
- Patient is unable to provide consent or complete study activities
- Patient is incarcerated
The study team makes the final eligibility decision.
Where it's taking place
- Newark, New Jersey, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Newark, New Jersey, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.